Drug Discovery in the era of large-scale genetics and genomics data

Add to your list(s) Download to your calendar using vCal

• Philippe Sanseau (Glaxo SmithKline)
• Wednesday 09 February 2022, 14:00-15:00
• CMS, Meeting Room 15.

If you have a question about this talk, please contact Samantha Noel.

Our intention is to deliver all Seminars in person, we will follow University Covid Guidance on this. Seminars are aimed mainly at MPhil CompBio students, but are open to anyone who wishes to attend by pre-booking with the Administrator

Drug discovery remains a very long and costly process with reducing attrition a major objective. We have shown previously that using human genetics evidence may increase the chance of success in the clinic for drug targets. In addition, functional genomics technologies that can measure or perturb the genome at scale can also be used to identify and validate new drug targets, support patient stratification or understanding of mechanism of action. In this talk, using examples. I will describe how the combination of large scale genetics and functional genomics data combined with analytics is impacting drug discovery.

This talk is part of the Computational and Systems Biology Seminar Series 2023 - 24 series.

This talk is included in these lists:

• All CMS Events
• All Talks (aka the CURE list)
• Biology
• CMS, Meeting Room 15
• CamBridgeSens
• Cambridge talks
• Computational and Systems Biology
• Computational and Systems Biology Seminar Series 2023 - 24
• Graduate-Seminars
• Life Science Interface Seminars
• Life Sciences
• Life Sciences
• ME Seminar
• PMRFPS's
• School of Physical Sciences
• Trust & Technology Initiative - interesting events
• custom
• my_list
• other talks
• se393's list

Note that ex-directory lists are not shown.